Top member reports
Company Report
Last edited 2 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#20
Performance (25m)
30.4% pa
Followed by
82
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Cancer Scare
Added 2 months ago

Yesterday PEB, the NZ headquartered and ASX listed company announced:

“Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) today notes that Novitas, the Medicare Administrative Contractor with jurisdiction for our US laboratory, on Thursday 9 January 2025 finalized a non-coverage determination that would end reimbursement for Cxbladder Triage, Detect and Monitor by Medicare”.

With the already sick PEB share price approaching stage IV terminal, on yesterdays news PEB dropped a further 60%.  Looks like PEB joins RHY (bowel cancer diagnosis), BDX (breast cancer diagnosis) and PIQ (Diabetic Kidney disease and endometriosis) as a full blown ASX Cancer Cluster. 

Sadly for everyone, no cure in sight.